- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,110,513
- Total 13F shares
- 86,705,205
- Share change
- -1,673,774
- Total reported value
- $15,256,042,920
- Put/Call ratio
- 71%
- Price per share
- $176.00
- Number of holders
- 619
- Value change
- -$242,114,800
- Number of buys
- 311
- Number of sells
- 295
Quarterly Holders Quick Answers
What is CUSIP 88033G407?
CUSIP 88033G407 identifies THC - TENET HEALTHCARE CORP - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 88033G407:
Top shareholders of THC - TENET HEALTHCARE CORP - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
9,917,642
|
$1,333,922,850 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.8%
from 13D/G
|
9,496,405
|
$1,277,266,475 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
9.8%
|
8,551,276
|
$1,150,146,649 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8.7%
|
7,596,544
|
$1,021,736,000 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
13D/G
|
Company |
4.4%
from 13D/G
|
4,172,556
|
$561,208,796 | — | 31 Mar 2025 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.9%
|
3,394,834
|
$456,605,173 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.5%
|
3,019,638
|
$406,141,311 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
2,201,075
|
$296,560,095 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
2.3%
|
1,962,314
|
$263,904,887 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.1%
|
1,866,557
|
$251,051,917 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
1,675,199
|
$225,297,067 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.9%
|
1,624,898
|
$218,548,782 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
1,263,016
|
$169,875,652 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,236,058
|
$166,249,801 | — | 31 Mar 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.4%
|
1,188,742
|
$159,885,799 | — | 31 Mar 2025 | |
| Boston Partners |
13F
|
Company |
1.3%
|
1,162,642
|
$156,318,170 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
903,270
|
$118,861,260 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.97%
|
848,360
|
$114,104,422 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.94%
|
815,126
|
$109,634,407 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.85%
|
736,252
|
$99,025,894 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.84%
|
728,264
|
$97,951,508 | — | 31 Mar 2025 | |
| THORNBURG INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
70,161
|
$94,366,545 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
660,052
|
$88,776,994 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.71%
|
616,583
|
$82,930,573 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.68%
|
593,084
|
$79,769,800 | — | 31 Mar 2025 | |
| BW Gestao de Investimentos Ltda. |
13F
|
Company |
0.61%
|
529,785
|
$71,256,083 | — | 31 Mar 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.59%
|
517,463
|
$69,598,775 | — | 31 Mar 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.56%
|
491,334
|
$66,084,423 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.54%
|
471,694
|
$63,442,843 | — | 31 Mar 2025 | |
| Khrom Capital Management LLC |
13F
|
Company |
0.54%
|
471,222
|
$63,379,359 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.54%
|
469,529
|
$63,151,651 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.53%
|
465,000
|
$62,542,500 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.52%
|
456,331
|
$61,376,524 | — | 31 Mar 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.52%
|
453,023
|
$60,433,268 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.43%
|
374,481
|
$50,367,695 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.42%
|
368,520
|
$49,565,941 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.38%
|
330,111
|
$44,399,931 | — | 31 Mar 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.35%
|
302,717
|
$40,715,526 | — | 31 Mar 2025 | |
| WEDGE CAPITAL MANAGEMENT L L P/NC |
13F
|
Company |
0.34%
|
300,527
|
$40,420,882 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.32%
|
281,535
|
$37,866,000 | — | 31 Mar 2025 | |
| Freestone Grove Partners LP |
13F
|
Company |
0.32%
|
277,498
|
$37,323,481 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.32%
|
276,969
|
$37,252,334 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.32%
|
276,286
|
$37,160,468 | — | 31 Mar 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.32%
|
275,000
|
$36,987,500 | — | 31 Mar 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.31%
|
271,633
|
$36,535,000 | — | 31 Mar 2025 | |
| Daniel J. Cancelmi |
3/4/5
|
Former EVP & CFO |
—
mixed-class rows
|
496,225
mixed-class rows
|
$35,889,100 | — | 29 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.3%
|
264,783
|
$35,613,314 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.3%
|
261,167
|
$35,127,906 | — | 31 Mar 2025 | |
| Ronald A. Rittenmeyer |
3/4/5
|
Former Executive Chairman, Director |
—
mixed-class rows
|
559,975
mixed-class rows
|
$34,737,337 | — | 30 Sep 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.29%
|
255,757
|
$34,399,296 | — | 31 Mar 2025 |
Institutional Holders of TENET HEALTHCARE CORP - Common Stock (THC) as of Q2 2025
As of 30 Jun 2025,
TENET HEALTHCARE CORP - Common Stock (THC) was held by
619 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,705,205 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, GLENVIEW CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Invesco Ltd., Boston Partners, GEODE CAPITAL MANAGEMENT, LLC, and AMERIPRISE FINANCIAL INC.
This page lists
620
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
557
Q2 2025 holders
619
Holder diff
62
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.